Mologen AG   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Berlin Germany (1998)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2010
NCT01208194
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now